Show simple item record

dc.contributor.authorCalmy, A
dc.contributor.authorPascual, F
dc.contributor.authorFord, N
dc.date.accessioned2008-05-23T14:06:06Z
dc.date.available2008-05-23T14:06:06Z
dc.date.issued2004-06-24
dc.identifier.citationHIV drug resistance. 2004, 350 (26):2720-1 N. Engl. J. Med.en
dc.identifier.issn1533-4406
dc.identifier.pmid15215494
dc.identifier.doi10.1056/NEJM200406243502621
dc.identifier.urihttp://hdl.handle.net/10144/27892
dc.descriptionTo access this article, click "Additional Links".en
dc.language.isoenen
dc.publisherMassachusetts Medical Societyen
dc.relation.urlhttp://content.nejm.org/cgi/content/full/350/26/2720?ijkey=Yz.yg5oibi37g&keytype=ref&siteid=nejmen
dc.rightsArchived with thanks to The New England Journal of Medicineen
dc.subject.meshAnti-Retroviral Agentsen
dc.subject.meshDeveloping Countriesen
dc.subject.meshDrug Resistance, Viralen
dc.subject.meshHIV Infectionsen
dc.subject.meshHumansen
dc.subject.meshReverse Transcriptase Inhibitorsen
dc.subject.meshTreatment Failureen
dc.titleHIV drug resistance.en
dc.identifier.journalThe New England Journal of Medicineen


This item appears in the following Collection(s)

Show simple item record